Vera Therapeutics
(NASDAQ) VERA
Vera Therapeutics Financials at a Glance
Market Cap
$2.95B
Revenue (TTM)
$0.00
Net Income (TTM)
$299.62M
EPS (TTM)
$-4.66
P/E Ratio
-8.87
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$41.38
Volume
59,116
Open
$37.81
Price
$41.38
Volume
59,116
Open
$37.81
Previous Close
$41.38
Daily Range
$37.81 - $41.40
52-Week Range
$18.53 - $56.05
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$41.38
Volume
59,116
Open
$37.81
Previous Close
$41.38
Daily Range
$37.81 - $41.40
52-Week Range
$18.53 - $56.05
VERA News
VERA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Vera Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
249
CEO
Marshall W. Fordyce, MD
Website
www.veratx.comHeadquarters
Brisbane, CA 94005, US
VERA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-51%
Return on Capital
-46%
Return on Assets
-41%
Earnings Yield
-11.27%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.95B
Shares Outstanding
71.36M
Volume
59.12K
Short Interest
0.00%
Avg. Volume
1.09M
Financials (TTM)
Gross Profit
$468.00K
Operating Income
$315.47M
EBITDA
$291.62M
Operating Cash Flow
$241.10M
Capital Expenditure
$630.00K
Free Cash Flow
$241.73M
Cash & ST Invst.
$714.59M
Total Debt
$77.31M
Vera Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$1.13M
N/A
Gross Margin
0.00%
N/A
Market Cap
$2.95B
N/A
Market Cap/Employee
$19.42M
N/A
Employees
152
N/A
Net Income
$91.10M
-109.8%
EBITDA
$85.34M
-105.6%
Quarterly Fundamentals
Net Cash
$637.28M
+8.7%
Accounts Receivable
$3.29M
-12.9%
Inventory
$0.00
N/A
Long Term Debt
$76.76M
+44.4%
Short Term Debt
$549.00K
-63.0%
Return on Assets
-40.78%
N/A
Return on Invested Capital
-46.31%
N/A
Free Cash Flow
$70.10M
-76.0%
Operating Cash Flow
$69.99M
-78.6%